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Background: Cardiac complications are often developed after subarachnoid hemorrhage (SAH) and may cause
sudden death of the patient. There are reports in the literature addressing ischemia modified albumin (IMA) as an
early and useful marker in the diagnosis of ischemic heart events. The aim of this study is to evaluate serum IMA
by using the albumin cobalt binding (ACB) test in the first, second, and seventh days of experimental SAH in rats.
Twenty-eight Wistar albino rats were divided into four groups each consisting of seven animals. These were
classified as control group, 1st, 2nd and 7th day SAH groups. SAH was done by transclival basilar artery puncture.
Blood samples were collected under anesthesia from the left ventricles of the heart using the cardiac puncture
method for IMA measurement. Histopathological examinations were performed on the heart and lung tissues.
Albumin with by colorimetric, creatine kinase (CK), aspartate aminotransferase (AST), lactate dehydrogenase (LDH)
were determined on an automatic analyser using the enzymatic method. IMA using by ACB test was detected with
spectrophotometer.
Results: Serum IMA (p = 0.044) in seventh day of SAH were higher compared to the control group. Total injury
scores of heart and lung tissue, also myocytolysis at day 7 were significantly higher than control group (p = 0.001,
p = 0.001, p = 0.001), day 1 (p = 0.001, p = 0.001, p = 0.001) and day 2 (p = 0.001, p = 0.007, p = 0.001). A positive
correlation between IMA - myocytolysis (r = 0.48, p = 0.008), and between IMA – heart tissue total injury score
(r = 0.41, p = 0.029) was found.
Conclusion: The results revealed that increased serum IMA may be related to myocardial stress after SAH.
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Cardiac effects of intracranial hemorrhage were initially
described in 1903 by Cushing, who noted alterations in
blood pressure and cardiac rhythm in patients [1].
There are three main theories explaining the pathogen-
esis of subarachnoid hemorrhage (SAH)-induced cardiac
dysfunction [2]. The first is a multi-vessel coronary artery
spasm causing ischemia. Microvascular dysfunction was
identified as an another factor. Catecholamine hypothesis
was the most responsible [2]. The catecholamine mediated* Correspondence: serefdenacikgoz@yahoo.com
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reproduction in any medium, provided the orinjury is the likely cause of cardiac damage [3-5]. Cathe-
colamine secretion, even in toxic amounts, from sym-
pathetic nerve terminals within the myocardium have
been reported [6].
In literature, cardiac complications, including cardiac
arrhytmias [7,8], wall motion abnormalities [7,9], left
ventricular dysfunction [10,11], myocardial necrosis [1,4],
pulmonary edema [12-14] were noted in SAH patients
and experimental SAH models.
The dramatic end of the afore mentioned abnormalities
was the sudden death of the patients.
In diagnosis, electrocardiographic changes [7-9,11,15,16]
and biochemical cardiac markers such as creatine kinasel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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[1,4,7,15] have been used.
Since in cardiac events the increases in serum amounts
of intracellular enzymes and proteins occur after tissue ne-
crosis [18], those mentioned markers may not be sensitive
in periods before necrosis or in cases where necrosis was
not found.
The N terminal of albumin molecule was the primary
site where transitional metals such as Co(II), Cu(II) and
Ni(II) bind [19]. During acute ischemic conditions, the
metal binding capacity of albumin for transition metals
is reduced to what is commonly known as ischemia
modified albumin (IMA) [20]. IMA may be potentially
used as an early marker of myocardial ischemia before
necrosis occurs [19,21,22]. Serum IMA was measured
using the albumin cobalt binding (ACB) test that measures
the binding capacity of albumin to cobalt [19]. It has been
approved by the US Food and Drug Administration [23].
In this study the role of IMA, as an early marker, in
myocardial stress after experimental SAH was investi-
gated. In rats, after experimental SAH, the changes in
IMA on the 1st, 2nd and 7th days were noted and com-
pared with control group animals. Also histopathologic
changes in heart and pulmonary tissues were investigated.
Methods
The study protocol was approved by the Bülent Ecevit
University (Formerly, Zonguldak Karaelmas University),
and the Animal Ethics commitee (Ethics approval num-
ber: B.30.2.Z.K.Ü.0.20.00.00/HADYEK-39).
Subjects
The animal study was performed at the Experimental
Surgery, Animal Care and Research Unit of Bulent Ecevit
University, Faculty of Medicine, Zonguldak. Twenty-eight
male adult Wistar albino rats, weight 200–300 g, were
included in the study. All rats were kept at standard
conditions, 21 ± 2°C, appropriate humidity, a 12 h-12 h
light–dark cycle, and given sufficient fluids and food.
The rats were divided into four groups as follows: first
day group (n = 7), second day group (n = 7), seventh
day group (n = 7) with SAH and control group (n = 7).
Surgical procedure
Rats were anesthetized by intraperitoneal injection of
ketamine (60 mg/kg) and xylazine (10 mg/kg). Experi-
mental SAH was created with a technique similar to that
described by Barry et al. [24]. Briefly, through a midline
cervical incision in the supine position, using an operating
microscope (Takagi OM-5, Japan) the anterior paraphar-
yngeal approach was used to expose the clivus. A bony
window in front of the basilar artery was created using
large bore needles with extreme care not to open the
prepontine cistern. A suture needle with an outerdiameter of 75 μm (Ethicon, Scotland, UK) was inserted
into the basilar artery. Withdrawal of the needle caused
an extensive hemorrhage into the subarachnoid space
with an even distribution up to the olfactory area.
The rats were kept alive for the 1st, 2nd, and 7th days,
after SAH under appropriate conditions.
Under anesthesia, blood samples of the animals were
collected using the cardiac puncture method from left
ventricles then the heart and lung tissues of the animals
were removed immediately for histopathologic evaluation.Laboratory tests
After the blood clotted, the samples were centrifuged
and the serum was immediately stored at −80°C until
assayed for analysis. Serum albumin levels (g/dL) using
the colorimetry method (Bromocresol Green [BCG]),
(intra-assay CV of < %1.1, inter-assay CV of < %1.8, ana-
lytical range 1-6 g/dL), creatine phosphokinase (CK U/L)
(intra-assay CV of < %1.9, inter-assay CV of < %4.6, analyt-
ical range 0-1300U/L), aspartate aminotransferase (AST
U/L) (intra-assay CV of < %2.5, inter-assay CV of < %3.3,
analytical range 0-1000U/L), and lactate dehydrogenase
(LDH U/L) (intra-assay CV of < %0.9, inter-assay CV
of < %1.3, analytical range 20-700U/L) activity using
the enzymatic method were assayed with Advia 2400
unit (Siemens, Tarrytown, USA).
The levels of serum IMA was measured by the ACB
test using Bar- Or’s method [19]. The purpose of the test
was the colorimetric measurement of coloured complex
of cobalt, unconjugated to serum albumin after cobalt-
albumin binding has occured, with ditiyotreitol (DTT).
Using a spectrophotometer (Shimadzu UV‐1601, Tokyo,
Japan) at 470 nm, color development with DTT was
compared to a serum-cobalt blank without DTT and
noted as absorbance unit (ABSU) (Intra-assay CV of < %
3.5 and inter-assay CV of < %6.1, analytical range 0.324-
0.897 ABSU).Histopathologic evaluation
Tissue specimens from the lung and heart were fixed in
10% neutral formalin solution and embedded in paraffin.
Sections were cut with a cryostat at 4–5 μm thickness
from the paraffin blocks of each tissue. Specimens were
then deparaffinized and stained with hematoxylin and
eosin (H&E). A pathologist microscopically examined
the H&E stained sections in blinded fashion, recording
results for each the lung and the heart tissue injury. A
light microscope was used for evaluation. Tissue damage
severity was semi-quantitatively assessed. Scores were
given as absent (0), slight change (1), moderate change
(2), and severe change (3) for each criteria. The injury
criteria used for each tissue for the scoring systems is
described below:
Table 2 Correlation coefficients of IMA and heart, lung
tissues total injury scores
(n =28) Correlation coefficient (r) p value
IMA-myocytolysis 0.480 0.008
IMA-heart total injury score 0.410 0.029
IMA-lung total injury score 0.250 0.191
IMA-LDH 0.103 0.601
IMA-AST 0.199 0.309
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http://www.biomedcentral.com/1471-2202/15/33Lung: 1) interstitial edema, 2) hemorrhage, 3) airway
epithelial-cell damage, 4) hyaline membrane formation,
5) neutrophil infiltration, 6) emphysematous changes, 7)
lymphocytic infiltration and 8) total lung injury score.
Heart: 1) myocardial edema, 2) myocytolysis, 3) focal
hemorrhage, 4) leukocytic infiltration, 5) loss of cross
striation, and 6) total lung injury score. The microscopic
score of each tissue was calculated as the sum of the
scores given to each criteria.IMA-CK 0.269 0.166
Significant difference (p < 0,05).
Statistical analysis
The Statistical Package for Social Sciences 13.0 (SPSS
Inc, Chicago, IL, USA) was used in all data analyses. The
results were expressed as median, minimum and max-
imum. The normality distribution of the variables was
tested using the Shapiro Wilk test. For the variables
without normal distribution, the Kruskal Wallis test was
used for the four group comparisons. The Mann Whitney
U-test with the Bonferroni adjustment was used for two
group comparisons of significant variables among the
four groups. Spearman’s correlation analysis was used
to determine the relationship between continuous variables
state measurement. p-values less than 0.05 were considered
statistically significant.Results
Biochemical findings
Seventh day group showed significantly enhanced Me-
dian ± (Min-Max) serum IMA values 0,798 (0,495 –
0,897) absorbance units (ABSU) compared with control
group 0,452 (0,347-0,614) ABSU (p = 0.044). Serum albu-
min, CK, AST, and LDH levels of the 1st, 2nd, and 7th day
groups did not have significant differences compared to
control group (p = 0.991, p = 0.077, p = 0,646, p = 0,178)
respectively (Table 1).
A positive correlation between the IMA - myocytolysis
(r = 0.48, p = 0.008) and between IMA–heart tissue total
injury score (r = 0.41, p = 0.029) were given in Table 2.
There were not significant correlation between IMA and
LDH (r = 0.103, p = 0.601), AST(r = 0.199, p = 0.309) and
CK(r = 0.269, p = 0.166) (Table 2).Table 1 Levels of LDH, AST, CK and IMA in the serum of SAH
Control group Day 1 group
n = 7 n = 7
IMA(ABSU) 0,452 (0,347 - 0,614) 0,553 (0,341 – 0,864)
Albumin (g/dL) 3,4 (3,1 – 4,0) 3,6 (3,1 – 3,8)
CK (U/L) 859 (532–2492) 533 (417–2508)
AST (U/L) 145 (99–178) 244 (118–315)
LDH (U/L) 635 (446–856) 618 (213–3054)
Median (Min - Max).
Significant difference (p < 0,05); *different from control group.Histopathologic findings
The histopathologic examination findings of lung and
heart tissues at days 1, 2 and 7 compared with normals
were given in Tables 3 and 4. Total injury scores of
heart tissues (p = 0.001, p = 0.001, p = 0.001), lung tis-
sues (p = 0.001, p = 0.001, p = 0.001) and myocytolysis
(p = 0.004, p = 0.001, p = 0.001) at days 1, 2 and 7 were
found significantly higher when compared with the
control group. Total injury scores of heart and lung tissue,
also myocytolysis at day 7 were significantly higher than
day 1 (p = 0.001, p = 0.001, p = 0.001) and day 2 (p = 0.001,
p = 0.007, p = 0.001).
Discussion
Cardiac complications after SAH may cause sudden death
[14,25]. There are studies in the literature adressing the
cardiac problems seen after SAH. The authors mostly
identified increased sympathetic activity.
In dogs, experimental studies revealed high plasma
catecholamine levels [4,5,9], myocardial necrosis [4],
micro infarctions with electron microscopy [9], left
ventricular dysfunction [5,11] and wall motion abnor-
malities [9].
In clinical studies, in SAH patients, chances of ECG,
high cardiac markers [1,7,15,25], wall motion abnormal-
ities [7,25] were noted. Szabo et al. investigated myocardial
perfusion with myocardial scintigraphy. They reported
that myocardial ischemia might be seen without specific
ECG changes [26].and normal rats
Day 2 group Day 7 group p value
n = 7 n = 7
0,700 (0,324 – 0,857) 0,798 (0,495 – 0,897)* 0.044
3,6 (3,1 – 3,9) 3,6 (3,3 – 3,7) 0.991
760 (638–2649) 1134 (340–11024) 0.077
151 (114–392) 223 (109–597) 0.646
1042 (469–5521) 1222 (447–3559) 0.178
Table 3 Median histopathologic scores for the lung and heart tissues from each group
Control group Day 1 group Day 2 group Day 7 group p
valuen = 7 n = 7 n = 7 n = 7
Lung
Interstitial edema 0 (0 – 1) 1 (1 – 2) 1 (1 – 2) 2 (2 – 3) <0,001
Hemorrhage 1 (0 – 1) 2 (2 – 2) 2 (2 – 2) 3 (2 – 3) <0,001
Epithelial injury 0 (0 – 1) 1 (1 – 2) 1 (1 – 2) 2 (1 – 2) <0,001
Hyalin membrane formation 0 (0 – 0) 1 (1 – 1) 1 (1 – 2) 2 (1 – 2) <0,001
Neutrophil infiltration 0 (0 – 1) 2 (1 – 2) 2 (1 – 2) 2 (2 – 3) <0,001
Emphysematous changes 0 (0 – 1) 1 (1 – 2) 2 (1 – 2) 2 (2 – 3) <0,001
Lymphocytic infiltration 1 (0 – 1) 1 (1 – 2) 2 (1 – 2) 2 (1 – 2) 0,017
Total injury score 2 (1 – 4) 9 (8 – 13) 11 (9 – 13) 15 (11 – 18) <0,001
Heart
Myocardial edema 0 (0 – 0) 1 (1 – 2) 1 (1 – 2) 2 (2 – 2) <0,001
Myocytolysis 0 (0 – 1) 1 (1 – 2) 2 (1 – 2) 3 (3 – 3) <0,001
Focal hemorrhage 0 (0 – 1) 1 (1 – 2) 2 (1 – 2) 3 (3 – 3) <0,001
Leukocytic infiltration 0 (0 – 0) 1 (0 – 2) 1 (1 – 2) 2 (1 – 2) <0,001
Loss of cross striation 0 (0 – 0) 1 (1 – 1) 1 (1 – 1) 2 (1 – 2) <0,001
Total injury score 0 (0 – 2) 5 (4 – 9) 7 (6 – 8) 11 (10 – 12) <0,001
Median (Min - Max).
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found necrosis of individual muscle fibers, increased
eosinophilia and granular cytoplasm, necrotic muscle
fibers surrounded by macrophages [3]. Sugiuro et al., in
a case report (50 year old women), noted ECG changes
indicating myocardial damage, high cardiac enzymes,Table 4 Inter groups significance in the lung and heart tissue
Control – Day1 Control – Day2
Lung
Interstitial edema 0,004 0,002
Hemorrhage 0,001 0,001
Epithelial injury 0,004 0,002
Hyalin membrane formation 0,001 0,001
Neutrophil infiltration 0,001 0,001
Emphysematous changes 0,007 0,001
Lymphocytic infiltration 0,038 0,017
Total injury score 0,001 0,001
Heart
Myocardial edema 0,001 0,001
Myocytolysis 0,004 0,001
Focal hemorrhage 0,026 0,001
Leukocytic infiltration 0,004 0,001
Loss of cross striation 0,001 0,001
Total injury score 0,001 0,001
Significant difference (p < 0,0083).hypokinetic left vetricular septum, pulmonary edema.
Autopsy of the patient revealed diffuse myocytolysis
with coagulation necrosis of the heart muscle without
the evidence of coronary artery occlusion [14]. Yuki
et al. in their case report reported ECG findings resembling
myocardial infarction in a patient. Left ventriculographys scores
p value
Control – Day7 Day1– Day2 Day1– Day7 Day2– Day7
0,001 0,710 0,002 0,011
0,001 1,000 0,260 0,026
0,001 0,710 0,260 0,073
0,001 0,209 0,260 0,383
0,001 1,000 0,128 0,128
0,001 0,209 0,170 0,128
0,017 0,710 0,710 1,000
0,001 0,209 0,001 0,007
0,001 0,710 0,004 0,026
0,001 0,073 0,001 0,001
0,001 0,073 0,001 0,001
0,001 0,456 0,128 0,383
0,001 1,000 0,026 0,260
0,001 0,026 0,001 0,001
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http://www.biomedcentral.com/1471-2202/15/33revealed cardiac dysfunction. Two months later, in the
postmortem examination of the patient, after her death
from cancer, no evidence of myocardial necrosis was
revealed [27]. The authors discussed coronary vasospasm
and reversible postischemic stunned myocardium without
necrosis which might happened after SAH [27].
In ischemic cardiac events, since intracellular enzymes
and proteins increase in serum after the occurence of
tissue necrosis [18], they may be insufficient in the diag-
nosis in the lack of necrosis or in cases where necrosis
did not happen yet. Sinha et al., examined IMA, ECG
and cTnT in patients who were admitted to an emergency
department with acute chest pain. The sensitivity (82%),
specifity (46%), negative predictive value (59%), positive
predictive value (72%) of IMA were calculated. On
contrary the sensitivity of ECG (45%) and cTnT (20%)
were noted. They underlined the possible role of IMA
in detecting ischemia before necrosis happen [28]. In
our experimental SAH study, in rats, we could not
demonstrate significant changes in CK, AST and LDH
tests when compared with control group at days 1, 2
and 7. There were significant increases of IMA at 7th
day after SAH compared with the control group. We
observed that the serum albumin values for all groups
did not differ from the control group, thus we can say
that high IMA in SAH may not be due to low albumin
levels.
In the light microscopic examination myocardial ne-
crosis was not seen in all groups but total injury scores
of heart and lung tissues at days 1, 2 and 7 were found
increased when compared to the control group. Also in
days 1, 2 and 7 myocytolysis, which was described by
Turillazzi as a specific histological marker of congestive
heart failure without relation to coronary blood flow,
myocardial hypoxia and myocardial fibrosis [29], was
found increased compared to the control group. Both total
injury scores of heart and lung tissues and myocytolysis of
heart tissue at days 7 were found significantly increased
compared to days 1 and 2.
In literature research we did not find an experimental
study investigating IMA after experimental SAH.
There were clinical studies in the literature referring
to increases of IMA after myocardial ischemia [19], tran-
sient myocardial ischemia [21], acute coronary syndrome
[22,28].
There were studies investigating IMA changes after
pulmonary emboli [30], skeletal muscle ischemia [31-33]
and cerebrovascular events including SAH [23,34].
Zapica-Muniz et al., after skeletal muscle forearm is-
chemia test, in their volunteer subjects, found decreased
levels of IMA at 1st, 3rd and 5th minutes compared to
baseline values, in addition to low ammonia and high
lactate levels. In lactate serum pool the authors found
decreased levels of IMA after increases in lactic acidconcentrations. The authors underlined the decreased
diagnostic sensitivity of IMA because of increased lactate
levels [31].
Roy et al., in their patients with peripheral vascular
disease (PVD) and leg claudication, performed an exercise
test inducing leg ischemia and found decreased levels of
IMA during stress peak. They also performed a dobutamin
stress echocardiography and found unchanged levels of
IMA. In their patients regional wall motion abnormalities
were not detected. They noted ischemia of tissues other
than myocardium might be responsible for decreases of
IMA [32].
IMA levels were found increased in volunteers of a
marathon race for 24–48 hours [33]. In another study
Falkensammer et al. noted increased IMA levels after calf
muscle ischemia induced by exercise in volunteers [35].
Sbarouni et al., in their review article, stated that the
changes of IMA after exercises were not homogenous,
they might be due to ischemic areas in the gastrointestinal
tract and skeletal muscle. They also underlined that the
role of hemoconcentration seen after physical exercises,
might cause increases of albumin serum levels and be-
cause of decreased unbound cobalt to albumin, IMA
might be lowered. They noted interference of lactic
acidosis with IMA analysis [36].
Han et al. demonstrated increases in IMA after cere-
bral infarction, intracerebral hemorrhage and SAH (18
patients) compared to control group and they stated a
positive correlation between IMA and lipid levels. In this
study, patients with pulmonary emboli and coronary ar-
tery thrombosis within 6 months were excluded [34].
Gündüz et al. examined and compared the levels of IMA
in intracerebral hemorrhage, SAH and brain infarction
patients within 24 hours after their symptoms started.
They found increased levels of IMA compared to con-
trol patients, and in brain infarction the increases were
significant compared to SAH, and they stated that this
finding might be used in differential diagnosis of SAH
with brain infarction. The authors excluded patients with
acute coronary syndrome, acute myocardial infarction,
cardiac insufficiency, and pulmonary embolism in their
study [23].
Conclusion
In our study we observed increased levels of IMA at
days 1 and 2 after SAH, in blood samples obtained by
cardiac pucture (left ventricle). We also observed signifi-
cantly higher levels of IMA at day 7. There was a posi-
tive correlation between the IMA and cardiac total
injury scores and the cardiac myocytolysis. Our study is
an isolated study compared to clinical studies. In the
light of our findings we can state that the increases of
IMA might be related to a probable myocardial stress
after SAH. We believe there is the need for futher
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IMA to detect cardiac stress which may cause the sudden
death of patients after SAH.
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